• Blood, Components and Plasma (August 17, 2009, Closing Date) -- FDA is soliciting questions and comments on the licensure requirements and license application procedures for whole blood and blood components, including source plasma, and requests comments on this topic.
  • Veterinary Drug (August 20, 2009, Closing Date) -- FDA is soliciting comments on its Draft Guidance for Industry on "Bracketing and Matrixing Designs for Stability Testing of New Veterinary Drug Substances and Medicinal Products."  
  • DTC Drug Ads (August 21, 2009, Closing Date) -- FDA is soliciting comments on the Experimental Study of Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer (DTC) Television and Print Advertisements for Prescription Drugs.  
  • Drug and Device Promotion (August 25, 2009, Closing Date) -- FDA is soliciting comments on its Draft Guidance for Industry, titled "Presenting Risk Information in Prescription Drug and Medical Device Promotion."  
  • Pistachios and Salmonella (August 28, 2009, Closing Date) -- FDA is soliciting comments on its Draft Guidance for Industry, titled "Measures to Address the Risk for Contamination by Salmonella Species in Food Containing a Pistachio-Derived Product as an Ingredient."  
  • Radioactive Drug Research (September 1, 2009, Closing Date) -- FDA is soliciting comments on its Draft Guidance for Industry and Researches, titled "The Radioactive Drug Research Committee: Human Research Without an Investigational New Drug Application."
  • Bioequivalence Recommendations (September 8, 2009, Closing Date) -- FDA is soliciting comments on Draft and Revised Draft Guidances for Industry describing product-specific bioequivalence (BE) recommendations.
  • LASIK Post-market Experiences (September 14, 2009, Closing Date) -- FDA is soliciting comments on post-market experience with the use of Laser-Assisted In Situ Keratomileusis (LASIK) Devices.